Sign inJoin waitlistJoin the waitlist

JM

John Mellors

Director of the HIV/AIDS Program at the University of Pittsburgh Medical Center · UPMC Medical Education

Credentials: · ·

History

UPMC Medical Education
Present

Research

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
New England Journal of Medicine · 1997 · 1,591 citations
Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection
Annals of Internal Medicine · 1997 · First of 12 authors · 1,572 citations
Antiretroviral-drug resistance among patients recently infected with HIV
New England Journal of Medicine · 2002 · 929 citations

DM
Deborah McMahon
48 papers
Joseph Eron
47 papers
Rajesh Gandhi
43 papers
Sharon Riddler
30 papers
DR
Douglas Richman
28 papers
Daniel Kuritzkes
23 papers
Ann Collier
20 papers
Steven Deeks
19 papers
CG
Catherine Godfrey
18 papers
Diane Havlir
16 papers
JP
John Phair
16 papers
SH
Scott Hammer
16 papers

Grants

I4C 2.0: Immunotherapy for Cure
National Institute of Allergy and Infectious Diseases · UM1
PI · $28M · Beth Israel Deaconess Medical Center
2021–2028
Pitt-Ohio State Clinical Trials Unit
National Institute of Allergy and Infectious Diseases · UM1
Contact PI · $38M · University of Pittsburgh at Pittsburgh
2007–2027
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure
National Institute of Allergy and Infectious Diseases · U01
PI · $7.4M · University of Pittsburgh at Pittsburgh
2017–2025
Pittsburgh HIV Mentored Training for Investigation of Co-Morbidities and Cure (HIV MeTrICC)
National Heart, Lung, and Blood Institute · K12
PI · $1.7M · University of Pittsburgh at Pittsburgh
2018–2024

Clinical trials

Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy
Principal investigator · Terminated
AIDS Malignancy Consortium
2011–2013
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure
Study chair · Completed · Phase 1
Sharon Riddler
2019–2025
Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
Study chair · Completed · Phase 1, Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2014–2018
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
Study chair · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2007–2008